Recent Advancements in Legal Aspects of Pharmaceuticals: A Comprehensive Review (2018–2024)

Authors

  • Deepak Prashar Department of Pharmacy, L R Institute of Pharmacy, Jabli-Kyar, Solan HP-India
  • Anita Verma Department of Law, L R Institute of Legal Studies, Jabli-Kyar, Solan (HP)-India.
  • Nidhi Thakur Department of Law, L R Institute of Legal Studies, Jabli-Kyar, Solan (HP)-India.
  • Chanchal Gautam Department of Law, L R Institute of Legal Studies, Jabli-Kyar, Solan (HP)-India.
  • Sneha Department of Law, L R Institute of Legal Studies, Jabli-Kyar, Solan (HP)-India.

Keywords:

Pharmaceutical law, Drug regulation, Intellectual property, Pharmacovigilance, Digital health, Compulsory licensing, Biosimilars, Product liability.

Abstract

Background: The pharmaceutical sector operates within a dynamic and complex legal framework that governs drug development, approval, manufacturing, intellectual property, pharmacovigilance, and market authorization. Rapid advancements in biotechnology, digital health, and personalized medicine have necessitated significant legislative reforms globally. Objectives: This review comprehensively examines recent (2018–2024) advancements in pharmaceutical law across drug regulatory affairs, intellectual property rights, product liability, pharmacovigilance, digital health regulation, compulsory licensing, and emerging global harmonization efforts. Methods: A systematic narrative review was conducted using PubMed, Scopus, LexisNexis, and regulatory agency databases. Peer-reviewed literature, legislative texts, and official regulatory guidance documents published between 2018 and 2024 were included. Results: Key advancements identified include the US FDCA amendments (2022), EU Regulation 2022/123, ICH E6 (R3) revisions, FDA's Digital Health Center of Excellence guidelines, TRIPS Agreement flexibilities during the COVID-19 pandemic, expansion of the Biologics Price Competition and Innovation Act (BPCIA) framework, and enhanced post-market surveillance mandates. Conclusion: Pharmaceutical law is evolving rapidly in response to technological innovation, global health emergencies, and equitable access imperatives. Stakeholders must proactively engage with emerging legal developments to ensure compliance and foster innovation.

Downloads

Published

2026-05-29

Issue

Vol. 12 No. 2 (2026): Vol 12. No. 2 (2026) Volume - 12 Issue - 2

Section

Articles

License

Rights and reuse terms depend on the individual article record. Articles accepted on or after 8 September 2026 are licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), provided appropriate credit is given, a link to the licence is supplied and changes are indicated. Earlier content remains governed by the rights and licence notice applicable to that article and is not retrospectively relicensed by this policy. Third-party material identified under a different notice is excluded from the journal licence.